Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta‐analysis
Open Access
- 7 February 2017
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 136 (1), 5-15
- https://doi.org/10.1111/acps.12699
Abstract
We aimed to assess whether individuals at ultra high risk (UHR) for psychosis have higher rates of cannabis use and cannabis use disorders (CUDs) than non-UHR individuals and determine whether UHR cannabis users have more severe psychotic experiences than non-users. We conducted a meta-analysis of studies reporting cannabis use in the UHR group and/or positive or negative symptoms among UHR cannabis users and non-users. Logit event rates were calculated for cannabis use, in addition to odds ratios to assess the difference between UHR and controls. Severity of clinical symptoms in UHR cannabis users and non-users was compared using Hedges’ g. Thirty unique studies were included (UHR n = 4205, controls n = 667) containing data from cross-sectional and longitudinal studies, and randomised control trials. UHR individuals have high rates of current (26.7%) and lifetime (52.8%) cannabis use, and CUDs (12.8%). Lifetime use and CUDs were significantly higher than controls (lifetime OR: 2.09; CUD OR: 5.49). UHR cannabis users had higher rates of unusual thought content and suspiciousness than non-users. Ultra high risk individuals have high rates of cannabis use and CUDs, and cannabis users had more severe positive symptoms. Targeting substance use during the UHR phase may have significant benefits to an individual's long-term outcome.Keywords
Funding Information
- Economic and Social Research Council (ES/J500094/1)
This publication has 72 references indexed in Scilit:
- Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosisTranslational Psychiatry, 2013
- Frequent alcohol, nicotine or cannabis use is common in young persons presenting for mental healthcare: a cross-sectional studyBMJ Open, 2013
- Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency departmentBMC Psychiatry, 2012
- Rationale and Baseline Characteristics of PREVENT: A Second-Generation Intervention Trial in Subjects At-Risk (Prodromal) of Developing First-Episode Psychosis Evaluating Cognitive Behavior Therapy, Aripiprazole, and Placebo for the Prevention of PsychosisSchizophrenia Bulletin, 2011
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysisSchizophrenia Bulletin, 2009
- Substance Use Disorders in Schizophrenia--Clinical Implications of ComorbiditySchizophrenia Bulletin, 2009
- Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosisSchizophrenia Research, 2008
- Prediction of Psychosis in Youth at High Clinical RiskArchives of General Psychiatry, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002